151 related articles for article (PubMed ID: 15800919)
1. Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer.
Korfage IJ; Essink-Bot ML; Borsboom GJ; Madalinska JB; Kirkels WJ; Habbema JD; Schröder FH; de Koning HJ
Int J Cancer; 2005 Aug; 116(2):291-6. PubMed ID: 15800919
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer.
Madalinska JB; Essink-Bot ML; de Koning HJ; Kirkels WJ; van der Maas PJ; Schröder FH
J Clin Oncol; 2001 Mar; 19(6):1619-28. PubMed ID: 11250990
[TBL] [Abstract][Full Text] [Related]
3. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
[TBL] [Abstract][Full Text] [Related]
4. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
[TBL] [Abstract][Full Text] [Related]
5. Responsiveness of the University of California-Los Angeles Prostate Cancer Index.
Bergman J; Saigal CS; Kwan L; Litwin MS
Urology; 2010 Jun; 75(6):1418-23. PubMed ID: 19589573
[TBL] [Abstract][Full Text] [Related]
6. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy.
Jayadevappa R; Chhatre S; Whittington R; Bloom BS; Wein AJ; Malkowicz SB
BJU Int; 2006 May; 97(5):955-62. PubMed ID: 16643477
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
[TBL] [Abstract][Full Text] [Related]
9. Cross-sectional survey of long-term quality of life after radical perineal prostatectomy.
Yang BK; Crisci A; Young MD; Silverstein AD; Peterson BL; Dahm P
Urology; 2005 Jan; 65(1):120-5. PubMed ID: 15667876
[TBL] [Abstract][Full Text] [Related]
10. Disease-specific symptoms and general quality of life of patients with prostate carcinoma before and after primary three-dimensional conformal radiotherapy.
Staff I; Salner A; Bohannon R; Panatieri P; Maljanian R
Cancer; 2003 Dec; 98(11):2335-43. PubMed ID: 14635067
[TBL] [Abstract][Full Text] [Related]
11. A 3-y prospective study of health-related and disease-specific quality of life in patients with nonmetastatic prostate cancer treated with radical prostatectomy or external beam radiotherapy.
Yoshimura K; Arai Y; Ichioka K; Matsui Y; Ogura K; Terai A
Prostate Cancer Prostatic Dis; 2004; 7(2):144-51. PubMed ID: 15111981
[TBL] [Abstract][Full Text] [Related]
12. Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: effects on health-related quality of life.
Jo Y; Junichi H; Tomohiro F; Yoshinari I; Masato F
BJU Int; 2005 Jul; 96(1):43-7. PubMed ID: 15963118
[TBL] [Abstract][Full Text] [Related]
13. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
[TBL] [Abstract][Full Text] [Related]
14. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.
Potosky AL; Legler J; Albertsen PC; Stanford JL; Gilliland FD; Hamilton AS; Eley JW; Stephenson RA; Harlan LC
J Natl Cancer Inst; 2000 Oct; 92(19):1582-92. PubMed ID: 11018094
[TBL] [Abstract][Full Text] [Related]
15. Health related quality of life in Japanese men after radical prostatectomy or radiation therapy for localized prostate cancer.
Namiki S; Tochigi T; Kuwahara M; Ioritani N; Terai A; Numata I; Satoh M; Saito S; Koinuma N; Arai Y
Int J Urol; 2004 Aug; 11(8):619-27. PubMed ID: 15285752
[TBL] [Abstract][Full Text] [Related]
16. [Quality of life after radiotherapy for prostate cancer].
Joly F; Degrendel AC; Guizard AV
Cancer Radiother; 2010 Oct; 14(6-7):519-25. PubMed ID: 20728393
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of health-related quality of life in patients with prostate cancer after treatment with radical retropubic prostatectomy and permanent prostate brachytherapy.
Dragićević S
Urol Int; 2010; 85(2):173-9. PubMed ID: 20606405
[TBL] [Abstract][Full Text] [Related]
18. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
Bradley EB; Bissonette EA; Theodorescu D
BJU Int; 2004 Nov; 94(7):1003-9. PubMed ID: 15541117
[TBL] [Abstract][Full Text] [Related]
19. Time course and predictors of symptoms after primary prostate cancer therapy.
Talcott JA; Manola J; Clark JA; Kaplan I; Beard CJ; Mitchell SP; Chen RC; O'Leary MP; Kantoff PW; D'Amico AV
J Clin Oncol; 2003 Nov; 21(21):3979-86. PubMed ID: 14581420
[TBL] [Abstract][Full Text] [Related]
20. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE.
Downs TM; Sadetsky N; Pasta DJ; Grossfeld GD; Kane CJ; Mehta SS; Carroll PR; Lubeck DP
J Urol; 2003 Nov; 170(5):1822-7. PubMed ID: 14532784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
